Steris | STE - Cost Of Sales


Steris reported $808.6M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
3M USD 3.82B 243M Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
CONMED USD 146.03M 12.43M Jun/2026
Cooper Companies USD 393.8M 17M Mar/2026
Dexcom USD 478.4M 36.8M Jun/2026
Ecolab USD 2.46B 180.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Fortive USD 401.5M 7.6M Jun/2026
Getinge SEK 3.97B 2.05B Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
Haemonetics USD 136.58M 11.56M Jun/2026
Idexx Laboratories USD 437.5M 19.42M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
J&J USD 8B 67M Jun/2026
Olympus JPY 83.57B 18.95B Jun/2026
Orthofix International USD 66.63M 6.4M Dec/2025
Owens Minor USD 436.92M 32.62M Dec/2025
ResMed USD 612.93M 61.26M Jun/2026
Steris USD 808.6M 82.7M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026